Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis - Coşkun, B N; Öksüz, M F; Ermurat, S (European journal of rheumatology, 2014)
et al.